𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Doxorubicin pharmacokinetics: the effect of abnormal liver biochemistry tests

✍ Scribed by Christopher J. Twelves; Nicola A. Dobbs; Helen C. Gillies; Christopher A. James; Robert D. Rubens; Peter G. Harper

Publisher
Springer
Year
1998
Tongue
English
Weight
289 KB
Volume
42
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of phenytoin on the pharmacokinet
Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbit
✍ Barry J. Cusack; Dwaine A. Tesnohlidek; Vicki L. Loseke; Robert E. Vestal; Dean πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 541 KB

Doxorubicin is metabolized extensively to doxorubicinol by the ubiquitous aldoketoreductase enzymes. The extent of conversion to this alcohol metabolite is important since doxorubicinol may be the major contributor to cardiotoxicity. Aldoketoreductases are inhibited in vitro by phenytoin. The presen

The effect of liver dysfunction on colch
The effect of liver dysfunction on colchicine pharmacokinetics in the rat
✍ Jonathan A. Leighton; Michael K. Bay; Alma L. Maldonado; Raymond F. Johnson; Ste πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 601 KB

Recent work has shown that colchicine may benefit patients with primary biliary or alcoholic cirrhosis. However, very little is known about its pharmacokinetics in the presence of impaired liver function. To study this w e examined the effects of three models of experimental liver dysfunction and on